EMA recommends orphan status for drug in AMLNovember 15, 2016Leukemia, Myelodysplasia, TransplantationPharmacyAML
FDA grants priority review for midostaurinNovember 15, 2016CythemiasLeukemia, Myelodysplasia, TransplantationPharmacyAML
Drug dubbed ‘breakthrough’ for CTCL subtypesNovember 12, 2016Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
CHMP recommends expanding use of drug in CLLNovember 11, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
FDA grants drug orphan designation for CTCLOctober 26, 2016Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Legislators question price of leukemia drugOctober 24, 2016Leukemia, Myelodysplasia, TransplantationPharmacyALLCML
CHMP recommends conditional approval of drug for CLLOctober 15, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma